PSNL News and Press, Personalis Inc. From 06/18/20

Personalis, Inc., (Nasdaq: PSNL) a leader in advanced genomics for cancer, today announced the company’s participation in the European Association for Cancer Research (EACR) 2020 Virtual Congress, which will be held online, June 18-19, 2020. Personalis will present “Enabling...

Personalis, Inc., (Nasdaq: PSNL) a leader in advanced genomics for cancer, today announced the company’s participation at the Precision: Breast Cancer Summit, which will be held online, June 16-17, 2020. Personalis will present “Enabling multidimensional tumor immunogenomics...

Personalis, Inc. (Nasdaq:PSNL), a leader in advanced genomics for cancer, today announced that, effective on June 15, 2020, the Compensation Committee of its Board of Directors granted non-qualified stock options to purchase an aggregate of 67,900 shares of its common stock and restricted sto...

Personalis, Inc. (Nasdaq:PSNL), a leader in advanced genomics for cancer, today announced the partnership with Berry Genomics, headquartered in the People’s Republic of China. Personalis will be expanding business operations in the People’s Republic of China in 2020, and pla...

Personalis, Inc. (Nasdaq: PSNL) today announced a collaboration with Sarepta Therapeutics (Nasdaq: SRPT), a leader in precision genetic medicine for rare disease. As part of this research collaboration, Sarepta will be working with the Personalis team to characterize immune response to precis...

Personalis, Inc., (Nasdaq: PSNL) a leader in advanced genomics for cancer, today announced that the company will present new data in abstracts to be presented at the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Meeting, which will be held May 29-31, 2020. One abstr...

Image source: The Motley Fool. Personalis, Inc.   (NASDAQ: PSNL) Q1 2020 Earnings Call May 07, 2020 , 5:00 p.m. ET Operator Continue reading

Personalis, Inc. (PSNL) Q1 2020 Earnings Conference Call May 07, 2020 5:00 PM ET Company Participants Caroline Corner – Westwicke ICR John West – President and Chief Executive Officer Aaron Tachibana – Chief Financial Officer Conference Call Participants ...

Personalis (NASDAQ: PSNL ): Q1 GAAP EPS of -$0.29 misses by $0.01 . More news on: Personalis, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today reported financial results for the first quarter ended March 31, 2020. First Quarter Highlights Reported record revenues of $19.2 million in the first quarter of 2020 versus $14.1 million in the first...